A study to explore the correlation of ABCB1, ABCG2, OCT1 genetic polymorphisms and trough level concentration with imatinib mesylate-induced thrombocytopenia in chronic myeloid leukemia patients

被引：0
|
作者：
Jose Francis
Biswajit Dubashi
Rajan Sundaram
Suresh Chandra Pradhan
Adithan Chandrasekaran
机构：
[1] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Department of Pharmacology
[2] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Department of Medical Oncology
[3] Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER),Department of Clinical Pharmacology
来源：
Cancer Chemotherapy and Pharmacology | 2015年 / 76卷
关键词：
Imatinib; Thrombocytopenia; Therapeutic drug monitoring; Pharmacogenetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1185 / 1189
页数：4
相关论文
共 50 条
  • [41] Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study
    Mahamadou Tandia
    Asma Mhiri
    Bernard Paule
    Raphaël Saffroy
    Valérie Cailliez
    Gaëlle Noé
    Robert Farinotti
    Laurence Bonhomme-Faivre
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 759 - 766
  • [42] Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study
    Tandia, Mahamadou
    Mhiri, Asma
    Paule, Bernard
    Saffroy, Raphael
    Cailliez, Valerie
    Noe, Gaelle
    Farinotti, Robert
    Bonhomme-Faivre, Laurence
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (04) : 759 - 766
  • [43] Pharmacogenomic Factors Such as the Expression of Imatinib Transporters (OCT-1, ABCB-1 and ABCG-2) at Diagnosis, OCT-1 SNPs, and Steady-State Imatinib and Desmethyl-Imatinib Trough Plasma Levels in De Novo Chronic Phase Chronic Myelogenous Leukemia, May Influence Disease Response to Imatinib.
    Labussiere, Helene
    Hayette, Sandrine
    Chabane, Kaddour
    Gagnieu, Marie-Claude
    Le, Quoc-Hung
    Tigaud, Isabelle
    Bernard, Joelle
    Barraco, Fiorenza
    Magaud, Jean-Pierre
    Michallet, Mauricette
    Nicolini, Franck E.
    BLOOD, 2008, 112 (11) : 914 - 914
  • [44] ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients
    Tiribelli, Mario
    Di Giusto, Sara
    Toffoletti, Eleonora
    Griguolo, Davide
    Penna, Domenico
    Maccari, Giorgia
    Medeot, Marta
    Fanin, Renato
    Damiani, Daniela
    BLOOD, 2017, 130
  • [45] Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy of a triple antiemetic combination in cancer patients receiving cisplatin-based chemotherapy: TRIPLE Pharmacogenomics Study
    Suzuki, K.
    Tsuji, D.
    Yokoi, M.
    Daimon, T.
    Nakao, M.
    Ayuhara, H.
    Kogure, Y.
    Shibata, K.
    Hayashi, T.
    Takeda, K.
    Nishio, M.
    Hama, T.
    Itoh, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S231 - S231
  • [46] Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia
    Maffioli, Margherita
    Camos, Mireia
    Gaya, Anna
    Hernandez-Boluda, Juan-Carlos
    Alvarez-Larran, Alberto
    Domingo, Abel
    Granell, Miquel
    Guillem, Vicent
    Vallansot, Rolando
    Costa, Dolors
    Bellosillo, Beatriz
    Colomer, Dolors
    Cervantes, Francisco
    LEUKEMIA RESEARCH, 2011, 35 (08) : 1014 - 1019
  • [47] Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia
    Harivenkatesh, Natarajan
    Kumar, Lalit
    Bakhshi, Sameer
    Sharma, Atul
    Kabra, Madhulika
    Velpandian, Thirumurthy
    Gogia, Ajay
    Shastri, Shivaram S.
    Biswas, Nihar Ranjan
    Gupta, Yogendra Kumar
    PHARMACOLOGICAL RESEARCH, 2017, 120 : 138 - 145
  • [48] Effect of Genetic Polymorphisms of ABCB1, ABCG2, and SLC22A1 on the Steady-State Plasma Concentrations of Lamotrigine in Treatment-Resistant Depressed Patients Treated With Lamotrigine Augmentation Therapy
    Tomori, Yoko
    Suzuki, Takeshi
    Mihara, Kazuo
    Nagai, Goyo
    Kagawa, Shoko
    Nakamura, Akifumi
    Nemoto, Kenji
    Kondo, Tsuyoshi
    CLINICAL NEUROPHARMACOLOGY, 2024, 47 (05) : 163 - 167
  • [49] Polymorphisms in the Human Organic Cation Transporter (hOCT1) (Solute Carrier Family 22, SLC22A1) and the Multidrug Resistance Gene (MDR1, ABCB1): Correlation with Imatinib Levels and Clinical Course in Chronic Myeloid Leukemia Patients
    Vine, Jacob
    Bar Cohen, Sara
    Ruchlemer, Rosa
    Goldschmidt, Neta
    Levin, Moshe
    Libster, Diana
    Gural, Alexander
    Gatt, Moshe E.
    Lavie, David
    Ben-Yehuda, Dina
    Rund, Deborah
    BLOOD, 2012, 120 (21)
  • [50] CORRELATION BETWEEN GENETIC POLYMORPHISMS OF THE MDR1, HOCT1 AND ORM1 GENES AND THE RESPONSE TO IMATINIB IN PATIENTS WITH NEWLY-DIAGNOSED CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML)
    Camos, M.
    Maffioli, M.
    Gaya, A.
    Hernandez-Boluda, J. C.
    Alvarez-Larran, A.
    Domingo, A.
    Granell, M.
    Guillem, V.
    Vallansot, R.
    Suarez-Lledo, M.
    Costa, D.
    Colomer, D.
    Cervantes, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 333 - 334
12345